Immune-Boosting Lung Cancer Therapy Shows Promise

FRIDAY, April 25 (HealthDay News) -- An immune-boosting treatment for lung cancer patients reduces the risk of cancer relapse after surgery to the same extent as chemotherapy but without the risk of unpleasant side effects, says a Phase II study by Belgian researchers.

Related Subjects

Geneva

Johan Vansteenkiste

European Lung Cancer Conference

National Cancer Institute

Medicine

Health and Fitness

Cancer

Lung Cancer

Clinical Trials

Surgery

Medical Treatments and Procedures

Powered by Inform

Related Articles

Minnesota Senate OKs restrictions on teen drivers Pioneer Press 4/28/2008 8:55:49 PM

Track the asbestos victims The Mercury, Australia 4/28/2008 7:45:13 PM

Pawlenty signs cancer study bill Grand Forks Herald 4/28/2008 6:34:58 PM

Possible Viral Links to Lung Cancer Risk Uncovered Yahoo! News 4/28/2008 3:09:16 PM

Call made for cancer inquiry Queensland Courier-Mail 4/28/2008 3:03:11 PM

Miami Jury Awards over $24 Million to Local Family NBC 4 Reno / Tahoe (KRNV) 4/28/2008 1:35:39 PM

Alfacell Announces Retirement of Chief Executive Officer NBC 4 Reno / Tahoe (KRNV) 4/28/2008 9:07:34 AM

Study Links HPV to Lung Cancer ABC News 4/28/2008 8:01:32 AM

Detecting Lung Disease TexomasHomepage.com 4/28/2008 5:56:01 AM

Minnesota Iron Range / House OKs study of miners' cancer Pioneer Press 4/27/2008 5:45:11 AM

Related Blogs

A vaccine against lung cancer? Discovering Biology in a Digital World 4/27/2008 6:28:41 PM

New genetic techniques to combat lung cancer PhysOrg.com 4/25/2008 11:04:17 AM

Mutation database helps personalized treatment of lung cancer EurekAlert! 4/25/2008 9:26:33 AM

Cancer immunotherapy shows long-term promise in lung cancer EurekAlert! 4/25/2008 3:09:06 AM

Powered by Inform